PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for Merck & Co Inc () from 1990 to Oct 30 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Merck & stock (MRK) PE ratio as of Oct 30 2020 is 16.79. More Details

Merck & PE Ratio (TTM) Chart

EMBED

Merck & PE Ratio (TTM) Historical Data

Total 1262
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Merck & PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2020-10-3016.8 2020-08-2820.9
2020-10-2916.8 2020-08-2720.9
2020-10-2816.9 2020-08-2620.9
2020-10-2717.3 2020-08-2520.9
2020-10-2617.4 2020-08-2420.8
2020-10-2317.7 2020-08-2120.7
2020-10-2217.5 2020-08-2020.7
2020-10-2117.3 2020-08-1920.7
2020-10-2017.3 2020-08-1820.6
2020-10-1917.4 2020-08-1720.7
2020-10-1617.7 2020-08-1420.4
2020-10-1517.5 2020-08-1320.4
2020-10-1417.8 2020-08-1220.2
2020-10-1317.9 2020-08-1119.7
2020-10-1217.8 2020-08-1019.7
2020-10-0917.8 2020-08-0719.8
2020-10-0817.8 2020-08-0619.8
2020-10-0717.7 2020-08-0519.9
2020-10-0617.6 2020-08-0419.9
2020-10-0518.0 2020-08-0320.1
2020-10-0217.9 2020-07-3119.6
2020-10-0118.1 2020-07-3019.3
2020-09-3018.4 2020-07-2919.4
2020-09-2918.1 2020-07-2819.4
2020-09-2818.3 2020-07-2719.3
2020-09-2520.2 2020-07-2418.8
2020-09-2420.3 2020-07-2319.0
2020-09-2320.2 2020-07-2219.2
2020-09-2220.2 2020-07-2119.2
2020-09-2120.3 2020-07-2019.4
2020-09-1820.9 2020-07-1719.5
2020-09-1720.9 2020-07-1619.4
2020-09-1620.9 2020-07-1519.4
2020-09-1520.5 2020-07-1419.1
2020-09-1420.5 2020-07-1318.9
2020-09-1120.6 2020-07-1018.7
2020-09-1020.4 2020-07-0918.7
2020-09-0920.7 2020-07-0819.0
2020-09-0820.3 2020-07-0719.2
2020-09-0720.8 2020-07-0619.4
2020-09-0420.8 2020-07-0319.2
2020-09-0320.9 2020-07-0219.2
2020-09-0221.2 2020-07-0119.1
2020-09-0120.6 2020-06-3018.9
2020-08-3120.8 2020-06-2918.6

Merck & PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Drug Manufacturers » NAICS : 325412 NAICS : 2834
Address 2000 Galloping Hill Road, Kenilworth, NJ, USA, 07033
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States.